NGT3

New Generation Technology (NGT), primarily operating through its NGT3 venture capital fund, is a premier life science and medical device incubator based in Nazareth, Israel. Founded in 2002 as a joint venture between Jewish and Arab entrepreneurs, NGT serves as a platform for early-stage startups to transition from innovative research to commercialized medical products. The incubator provides portfolio companies with essential resources, including seed funding, management support, and specialized laboratory infrastructure. NGT is particularly focused on therapeutic areas such as oncology, neonatal care, and cardiovascular health, leveraging its unique position to tap into the scientific talent of the Israeli-Arab sector. Through its collaboration with the Israel Innovation Authority, NGT has successfully launched numerous startups that have reached clinical and commercial stages. The organization’s 'triple bottom line' approach emphasizes financial returns, technological value creation, and social inclusion.